Table 1

Epimastigotes treated for 96h (× 10^*6 mL)
Compound	Control	0.1mM	1mM	5mM	10mM
1	9.5 ± 0.1	1.4 ± 0.07	1 ± 0.05	0.5 ± 0.07	0
2	17 ± 1	9.8 ± 0.07	8 ± 0.07	2 ± 0.4	0
3	22 ± 2	17 ± 1.4	11 ± 1	0.5 ± 0.1	0
4	28 ± 1	24 ± 1	21 ± 1	19 ± 2	0
5	9 ± 0.4	6 ± 0.1	4 ± 0.1	1.2 ± 0.2	0
6	9 ± 0.6	1.6 ± 0.4	1 ± 0.2	0	0
7	8 ± 0.5	5 ± 0.4	1.6 ± 0.1	0	0
8	8 ± 0.2	3.4 ± 0.07	1.6 ± 0.07	0	0
9	12 ± 0.3	1.4 ± 0.3	1.4 ± 0.1	0	0
10	10 ± 0.3	7.4 ± 0.2	3 ± 0.4	1.2 ± 0.2	0
11	10 ± 0.4	7 ± 0.4	3 ± 0.4	1.8 ± 0.2	0
12	10 ± 0.4	7 ± 0.3	3 ± 0.4	1.9 ± 0.4	0
13	9 ± 0.5	1.4 ± 0.1	1 ± 0.1	0	0
14	11 ± 0.7	5 ± 0.2	4 ± 0.1	1.3 ± 0.2	0
HU	36 ± 2	33 ± 1.8	7 ± 0.5	3.6 ± 0.5	2.4 ± 0.1
BZN	14 ± 1.4	0	0	0	0

Table 1: Epimastigotes of Trypanosomacruzi incubated with compounds (1–14), hydroxyurea (HU) and benznidazole (BZN) (96 h) at 28°C and pH 7.2. Each bar represents the standard deviation. Values are mean ± SD (n=3). The toxic effect of treatment was measured by growing the parasites in LIT for 96 h and quantifying cell live.